Literature DB >> 19216071

Prevalence of patients with colorectal cancer requiring follow-up or active treatment.

Marion Chauvenet1, Côme Lepage, Valérie Jooste, Vanessa Cottet, Jean Faivre, Anne-Marie Bouvier.   

Abstract

INTRODUCTION: The objective of this study was to estimate prevalence of colorectal cancers requiring care or follow-up.
MATERIALS AND METHODS: Prevalence was observed in 2005 on the population-based digestive cancer registry of Burgundy (France). Total and 5-year partial prevalences were calculated. The prevalence of patients requiring follow-up was estimated using non-mixture cure models. The prevalence of patients with recurrence was estimated using annual recurrence rates.
RESULTS: Total prevalence was 262,244 cases in France. The mean variation in 5-year partial prevalence between successive 5-year periods was +8.0%. Time to cure was estimated to be 9.3 years, suggesting that follow-up is needed over a 10-year period, corresponding to 71.7% of prevalent cases. In 2005, 5.4% of prevalent cases had recurrent cancer requiring treatment.
CONCLUSION: This study underlines the burden of colorectal cancer on the health system. Prevalence of patients requiring follow-up or treatment provides interesting information in addition to classic indicators.

Entities:  

Mesh:

Year:  2009        PMID: 19216071     DOI: 10.1016/j.ejca.2009.01.012

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  7 in total

1.  Rectal Cancer Surveillance-Recurrence Patterns and Survival Outcomes from a Cohort Followed up Beyond 10 Years.

Authors:  Winson Jianhong Tan; Hiang Jin Tan; Sreemanee Raaj Dorajoo; Fung Joon Foo; Choong Leong Tang; Min Hoe Chew
Journal:  J Gastrointest Cancer       Date:  2018-12

Review 2.  Perspectives of gold nanoparticles and their applications in pancreatic cancer (Review).

Authors:  Anamaria Magdalena Tomşa; Andreea Liana Răchişan; Andreea Alexandra Aldea; Lorena Ciumărnean
Journal:  Exp Ther Med       Date:  2021-01-25       Impact factor: 2.447

3.  Projections of cancer prevalence by phase of care: a potential tool for planning future health service needs.

Authors:  Xue Qin Yu; Mark Clements; Dianne O'Connell
Journal:  J Cancer Surviv       Date:  2013-08-07       Impact factor: 4.442

4.  Estimating the number of colorectal cancer patients treated with anti-tumour therapy in 2015: the analysis of the Czech National Cancer Registry.

Authors:  Tomáš Pavlík; Ondřej Májek; Jan Mužík; Jana Koptíková; Lubomír Slavíček; Jindřich Fínek; David Feltl; Rostislav Vyzula; Ladislav Dušek
Journal:  BMC Public Health       Date:  2012-02-10       Impact factor: 3.295

5.  Hazard rate of tumor recurrence over time in patients with colon cancer: implications for postoperative surveillance from three Japanese Foundation for Multidisciplinary Treatment of Cancer (JFMC) clinical trials.

Authors:  Hiromichi Maeda; Kosuke Kashiwabara; Toru Aoyama; Koji Oba; Michitaka Honda; Shuhei Mayanagi; Mitsuro Kanda; Chikuma Hamada; Sotaro Sadahiro; Junichi Sakamoto; Shigetoyo Saji; Takaki Yoshikawa
Journal:  J Cancer       Date:  2017-10-23       Impact factor: 4.207

6.  Evaluation of prognostic factors and clinicopathological patterns of recurrence after curative surgery for colorectal cancer.

Authors:  Filippo Melli; Ilenia Bartolini; Matteo Risaliti; Rosaria Tucci; Maria Novella Ringressi; Paolo Muiesan; Antonio Taddei; Amedeo Amedei
Journal:  World J Gastrointest Surg       Date:  2021-01-27

Review 7.  On estimating the time to statistical cure.

Authors:  Lasse H Jakobsen; Therese M-L Andersson; Jorne L Biccler; Laurids Ø Poulsen; Marianne T Severinsen; Tarec C El-Galaly; Martin Bøgsted
Journal:  BMC Med Res Methodol       Date:  2020-03-26       Impact factor: 4.615

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.